Dutasteride/tamsulosin

Drug Profile

Dutasteride/tamsulosin

Alternative Names: Combodart; Duodart; Jalyn; Tamsulosin/dutasteride

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antiandrogens; Azasteroids; Small molecules; Sulfonamides
  • Mechanism of Action Alpha 1a adrenergic-receptor antagonists; Cholestenone 5-alpha reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Benign prostatic hyperplasia

Most Recent Events

  • 01 Oct 2015 GlaxoSmithKline completes a phase I pharmacokinetics trial (In volunteers) in USA (NCT02509104)
  • 01 Jul 2015 GlaxoSmithKline initiates a phase I pharmacokinetics trial (In volunteers) in USA (NCT02509104)
  • 01 Feb 2015 GlaxoSmithKline completes a phase I bioavailability trial in Healthy volunteers in USA (NCT02184585)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top